Clinical Trial Update: Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports results from a Phase 1/2 study evaluating a three-drug combination of gefitinib, trastuzumab, and docetaxel in patients with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)
• Iressa (gefitinib)
• Taxotere (docetaxel)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-02-27